drugset / Trial / NCT05557370
Immunogenicity of HPV Vaccine in Transplant Recipients.
Phase 4
Active not recruiting
30 enrolled
Medical College of Wisconsin
Merck Sharp & Dohme LLC · collab
NaSingle-groupOpen-labelPrevention
Summary
To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2028-12-31
- Completion
- 2035-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gardasil 9 | Vaccine | — | — |